We are live on ! Find out more
PAM

Palisade Asset Management Portfolio holdings

AUM $1.08B
1-Year Est. Return 22.62%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+22.62%
3 Year Est. Return
+61.8%
5 Year Est. Return
+76.07%
10 Year Est. Return
+251.97%
AUM
$476M
AUM Growth
+$20.7M
Cap. Flow
+$1.72M
Cap. Flow %
0.36%
Top 10 Hldgs %
35.7%
Holding
136
New
4
Increased
44
Reduced
30
Closed
4

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$1.72M
2
DE icon
Deere & Co
DE
+$1.66M
3
GE icon
GE Aerospace
GE
+$1.64M
4
BAX icon
Baxter International
BAX
+$1.35M
5
HPQ icon
HP
HPQ
+$1.13M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.83M
2
SYK icon
Stryker
SYK
+$3.27M
3
ADM icon
Archer Daniels Midland
ADM
+$3.05M
4
MDU icon
MDU Resources
MDU
+$277K
5
PII icon
Polaris
PII
+$251K

Sector Composition

Rank Sector Weight
1 Healthcare 16.55%
2 Industrials 14.16%
3 Technology 14%
4 Materials 13.67%
5 Consumer Staples 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
26
Qualcomm
QCOM
$177B
$7.94M 1.67%
100,290
+5,708
+6% +$454K
BDX icon
27
Becton Dickinson
BDX
$44B
$7.94M 1.67%
68,788
– –
OMC icon
28
Omnicom Group
OMC
$23.5B
$7.79M 1.64%
109,335
+3,275
+3% +$228K
UNH icon
29
UnitedHealth
UNH
$380B
$7.13M 1.5%
87,168
-60
-0.1% -$4.72K
APA icon
30
APA Corp
APA
$12.5B
$6.67M 1.4%
66,324
+445
+0.7% +$40.3K
STJ
31
DELISTED
St Jude Medical
STJ
$4.36M 0.92%
63,025
+150
+0.2% +$9.72K
JNJ icon
32
Johnson & Johnson
JNJ
$645B
$4.2M 0.88%
40,096
-130
-0.3% -$13.1K
MDT icon
33
Medtronic
MDT
$108B
$3.9M 0.82%
61,179
+303
+0.5% +$18.4K
CBK
34
DELISTED
Christopher & Banks Corporation
CBK
$3.89M 0.82%
443,895
– –
AMGN icon
35
Amgen
AMGN
$203B
$3.75M 0.79%
31,699
+1,720
+6% +$199K
TGT icon
36
Target
TGT
$63.5B
$3.74M 0.79%
64,528
+2,774
+4% +$163K
WFC icon
37
Wells Fargo
WFC
$264B
$3.35M 0.7%
63,656
+1,450
+2% +$72.9K
ABBV icon
38
AbbVie
ABBV
$457B
$3.3M 0.69%
58,529
– –
CSCO icon
39
Cisco
CSCO
$448B
$3.22M 0.68%
129,669
+1,280
+1% +$30.5K
KMB icon
40
Kimberly-Clark
KMB
$36.9B
$3.01M 0.63%
28,224
– –
ECL icon
41
Ecolab
ECL
$76.4B
$2.82M 0.59%
25,302
-860
-3% -$92.2K
INTC icon
42
Intel
INTC
$452B
$2.75M 0.58%
88,892
-1,500
-2% -$41.1K
USB icon
43
US Bancorp
USB
$98.8B
$2.63M 0.55%
60,606
-555
-0.9% -$23.2K
DCI icon
44
Donaldson
DCI
$10.7B
$2.6M 0.55%
61,387
– –
SYK icon
45
Stryker
SYK
$129B
$2.54M 0.53%
30,125
-40,020
-57% -$3.27M
ORCL icon
46
Oracle
ORCL
$345B
$2.47M 0.52%
61,011
+300
+0.5% +$12.3K
COP icon
47
ConocoPhillips
COP
$143B
$2.13M 0.45%
24,887
+35
+0.1% +$2.73K
SLB icon
48
SLB Ltd
SLB
$77.8B
$2.09M 0.44%
17,682
-818
-4% -$84.3K
TJX icon
49
TJX Companies
TJX
$174B
$2.08M 0.44%
78,360
-2,760
-3% -$78.7K
T icon
50
AT&T
T
$168B
$2.04M 0.43%
76,303
+1,919
+3% +$51.4K
1
2
3 4 5

Similar funds

CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
EG
Electrum Group New York $1.08B AUM
HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.08B AUM 7.99% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
ACP
Atalan Capital Partners New York $1.08B AUM 75.27% 1-Year Est. Return
FNT
First Nebraska Trust Lincoln, Nebraska $1.08B AUM 14.75% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.08B AUM 20.09% 1-Year Est. Return
SI
Sora Investors Bryn Mawr, Pennsylvania $1.09B AUM 36.44% 1-Year Est. Return

Palisade Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Palisade Asset Management held 136 positions worth $476M, up 4.5% from $456M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Palisade Asset Management's Q2 2014 filing shows 4 new, 44 increased, 30 reduced and 4 closed positions. Its largest new stake was Enterprise Products Partners: 9,920 shares worth $388K. The largest sale was Merck, an estimated $3.83M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

  • Palisade Asset Management's largest Q2 2014 buy was Enterprise Products Partners: 9,920 shares worth $388K.
  • Palisade Asset Management added most to IBM in Q2 2014, an estimated $1.72M increase.
  • Palisade Asset Management's biggest Q2 2014 reduction was Merck, cutting an estimated $3.83M.
  • Palisade Asset Management fully exited Polaris in Q2 2014, selling an estimated $251K.
  • Palisade Asset Management's ten largest holdings make up 36% of its $476M portfolio in Q2 2014.
  • Palisade Asset Management opened 4 new positions and closed 4 in Q2 2014.
  • Palisade Asset Management's portfolio value rose 4.5% quarter-over-quarter to $476M.

Based on Palisade Asset Management's 13F filing for Q2 2014, filed 25 Jul 2014.